OVERVIEW

Antiarrhythmic Pharmacology in Atrial and Ventricular Arrhythmias is organized by American Association of Critical-Care Nurses (AACN).

Released/Updated: Nov 1, 2018
Expires: Dec 31, 2020

Accreditation:
• Contact Hours: 1.25
• CERP A : 1.25
• Pharmacology Hours 1.25
• AACN programming meets the standards for most states that require mandatory continuing education contact hours for license and/or certification renewal.

Activity Summary:
Antiarrhythmic pharmacological agents are used in both the emergent and long-term management of cardiac arrhythmias. These agents have a very powerful impact on the cardiac action potential and as a result, have the potential for proarrhythmic effects. This session links the actions of these medications to the cardiac action potential to provide a physiological framework for understanding. Discussion features utilization of these medications for atrial, ventricular and other cardiac arrhythmias. An algorithm, based on patient- and drug-specific features, is used to guide clinical decision-making. The results of recent clinical trials for antiarrhythmic medications are also discussed. Evidence from the American College of Cardiology, American Heart Association and Heart Rhythm Society for the management of supraventricular, atrial, and ventricular arrhythmias is integrated to provide a comprehensive patient-centered approach to the utilization of these agents. Pharmacology content = 100%.

Objectives:
• Correlate the action of antiarrhythmic agents with their effect on the action potential.
• Discuss the role of antiarrhythmic agents in the management of atrial, ventricular and other cardiac arrhythmias.
• Describe key considerations in prescribing, administering and evaluating the effect of antiarrhythmic medications.

Topics: Cardiovascular, ECG, Pharmacology

Level: AdvancedBeginner

Population: Adult

Role: APRN

Additional details will be posted as soon as information is available.